{"schema_version":"secwatch.filing_event.v1","accession":"0001530950-24-000353","form_type":"8-K","ticker":"POST","cik":"0001530950","company_name":"Post Holdings, Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.712217+00:00","generated_at":"2026-05-30T00:26:52.984694+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Post Holdings Q4 net sales $2.0B, Adj EBITDA $348.7M; FY2025 guidance $1.41B-$1.46B","bullets":["Q4 FY2024 net sales $2.0B, operating profit $190.9M, net earnings $81.6M, Adj EBITDA $348.7M.","FY2024 net sales $7.9B, operating profit $793.5M, net earnings $366.7M, Adj EBITDA $1,403.6M.","FY2025 Adj EBITDA guidance $1.41B-$1.46B.","Board retirements: Robert E. Grote and Ellen F. Harshman retiring effective Jan 30, 2025, no disagreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001530950-24-000353","json":"https://secwatch.observer/filing/0001530950-24-000353.json","markdown":"https://secwatch.observer/filing/0001530950-24-000353.md","text":"https://secwatch.observer/filing/0001530950-24-000353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/post-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:26:52.984694+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"143278562e","claim":"Ellen F. Harshman retired as Director at Post Holdings, Inc..","evidence_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","confidence":0.95},{"claim_id":"c388467f01","claim":"Robert E. Grote retired as Director at Post Holdings, Inc..","evidence_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001185185-26-002273","ticker":"DGAC","company_name":"DISCIPLINED GROWTH ACQUISITION Corp","filed_at":"2026-06-01T20:15:34+00:00","headline":"Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-26-002273","json":"https://secwatch.observer/filing/0001185185-26-002273.json","markdown":"https://secwatch.observer/filing/0001185185-26-002273.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/dgac8k052926.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","comparable_excerpt":"John W. Heilshorn, Aaron Spool, Michael Faber, John Ziegelman and Jay Gettenberg (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2111038/000118518526002273/0001185185-26-002273-index.htm"}},{"accession":"0001193125-26-249692","ticker":"ELOX","company_name":"Eloxx Pharmaceuticals, Inc.","filed_at":"2026-06-01T11:00:19+00:00","headline":"Eloxx Pharma: 1-for-11 reverse stock split effective May 29; appoints two independent directors","event_type":"other_material","sec_items":["3.02","3.03","5.03","5.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249692","json":"https://secwatch.observer/filing/0001193125-26-249692.json","markdown":"https://secwatch.observer/filing/0001193125-26-249692.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/0001193125-26-249692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/d261568d8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","comparable_excerpt":"the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) appointed Stephen W. Webster and Nina Kjellson to fill vacancies on the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1035354/000119312526249692/0001193125-26-249692-index.htm"}},{"accession":"0001104659-26-068521","ticker":"FDXF","company_name":"FedEx Freight Holding Company, Inc.","filed_at":"2026-06-01T10:46:03+00:00","headline":"FedEx Freight completes spin-off from FedEx; $600M drawn, new board and executives appointed","event_type":"other_material","sec_items":["1.01","2.03","3.03","5.03","5.01","5.02","5.05","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068521","json":"https://secwatch.observer/filing/0001104659-26-068521.json","markdown":"https://secwatch.observer/filing/0001104659-26-068521.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/tm2615735d2_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","comparable_excerpt":"each of John A. Smith, R. Brad Martin, Jeffrey A. Davis, Donald E. Frieson, Stephen E. Gorman, Robert A. King, Cindy J. Miller, Amy J. Salcido, and Samantha M. Smith was appointed to the Board","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2082247/000110465926068521/0001104659-26-068521-index.htm"}},{"accession":"0001171843-26-003809","ticker":"CRMT","company_name":"AMERICAS CARMART INC","filed_at":"2026-05-29T21:30:17+00:00","headline":"America's Car-Mart forms special committee for strategic alternatives; appoints new independent director","event_type":"other_material","sec_items":["1.01","5.02","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003809","json":"https://secwatch.observer/filing/0001171843-26-003809.json","markdown":"https://secwatch.observer/filing/0001171843-26-003809.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/0001171843-26-003809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/f8k_052926.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","comparable_excerpt":"On May 22, 2026, the Board increased the size of the Board from nine members to ten members and appointed Adam Paul as an independent director, effective immediately.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/799850/000117184326003809/0001171843-26-003809-index.htm"}},{"accession":"0000947871-26-000585","ticker":"MVST","company_name":"Microvast Holdings, Inc.","filed_at":"2026-05-28T21:26:49+00:00","headline":"Microvast CEO converts $25M loan to equity; CAO Eric Garcia departs","event_type":"other_material","sec_items":["5.02","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-26-000585","json":"https://secwatch.observer/filing/0000947871-26-000585.json","markdown":"https://secwatch.observer/filing/0000947871-26-000585.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1760689/000094787126000585/0000947871-26-000585-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1760689/000094787126000585/ss6384648_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","comparable_excerpt":"On May 27, 2026, Eric N. Garcia ceased to be employed as Chief Accounting Officer of Microvast Holdings, Inc. (the “Company”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1760689/000094787126000585/0000947871-26-000585-index.htm"}},{"accession":"0001493152-26-026544","ticker":"LIXT","company_name":"LIXTE BIOTECHNOLOGY HOLDINGS, INC.","filed_at":"2026-06-01T12:55:34+00:00","headline":"Lixte Biotechnology pivots to AI energy infrastructure; appoints Denham Capital founder to board","event_type":"other_material","sec_items":["5.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026544","json":"https://secwatch.observer/filing/0001493152-26-026544.json","markdown":"https://secwatch.observer/filing/0001493152-26-026544.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/form8-k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","comparable_excerpt":"On May 29, 2026, the Board of Directors (the “Board”) of Lixte Biotechnology Holdings, Inc., (the “Company”), appointed Stuart D. Porter to serve as a member of the Board, effective May 29, 2026 with a term expiring at the Company’s 2026 Annual Meeting of Stockholders.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1335105/000149315226026544/0001493152-26-026544-index.htm"}},{"accession":"0001829126-26-005831","ticker":"FXAC","company_name":"FortuneX Acquisition Corp","filed_at":"2026-05-29T21:32:49+00:00","headline":"FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-005831","json":"https://secwatch.observer/filing/0001829126-26-005831.json","markdown":"https://secwatch.observer/filing/0001829126-26-005831.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/fortunexacq_8k.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","comparable_excerpt":"Effective May 19, 2026, in connection with the effectiveness of the Company’s Registration Statement, Becky Fallon, Sean Michael Deegan, and Robert Labbe became members of the board of directors (the “Board”) of the Company.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm"}},{"accession":"0001636282-26-000056","ticker":"SYRE","company_name":"Spyre Therapeutics, Inc.","filed_at":"2026-05-29T20:45:58+00:00","headline":"Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns","event_type":"other_material","sec_items":["5.02","5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: executive_change","same SEC item: 5.02, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001636282-26-000056","json":"https://secwatch.observer/filing/0001636282-26-000056.json","markdown":"https://secwatch.observer/filing/0001636282-26-000056.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/0001636282-26-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/syre-20260527.htm"},"side_by_side_evidence":{"fact_type":"executive_change","source_excerpt":"On November 12, 2024, Robert E. Grote and Ellen F. Harshman, members of the Company’s Board of Directors (the “Board”), notified the Company of their decisions to retire as directors of the Company.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1530950/000153095024000353/0001530950-24-000353-index.htm","comparable_excerpt":"In addition, effective as of May 27, 2026, Peter Harwin resigned from the Board.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1636282/000163628226000056/0001636282-26-000056-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}